Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis.

Freund C, Wahlers A, Begli NH, Leopold Y, Klöters-Plachky P, Mehrabi A, Mohr I, Sander J, Rupp C, Gotthardt DN, Weiss KH.

Clin Res Hepatol Gastroenterol. 2020 Jan 9. pii: S2210-7401(19)30268-2. doi: 10.1016/j.clinre.2019.12.006. [Epub ahead of print]

PMID:
31928970
2.

Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities.

Goeppert B, Folseraas T, Roessler S, Kloor M, Volckmar AL, Endris V, Buchhalter I, Stenzinger A, Grzyb K, Grimsrud MM, Gornicka B, von Seth E, Reynolds GM, Franke A, Gotthardt DN, Mehrabi A, Cheung A, Verheij J, Arola J, Mäkisalo H, Eide TJ, Weidemann S, Cheville JC, Mazza G, Hirschfield GM, Ponsioen CY, Bergquist A, Milkiewicz P, Lazaridis KN, Schramm C, Manns MP, Färkkilä M, Vogel A; International PSC study group, Boberg KM, Schirmacher P, Karlsen TH.

Hepatology. 2020 Jan 10. doi: 10.1002/hep.31110. [Epub ahead of print]

PMID:
31925805
3.

Intrahepatic biliary strictures after liver transplantation are morphologically similar to primary sclerosing cholangitis but immunologically distinct.

Zhou T, Bartelheimer K, Ruping F, Rupp C, Sauer P, Koschny R, Mehrabi A, Mieth M, von Haken R, Weiss KH, Gotthardt DN, Rauber C.

Eur J Gastroenterol Hepatol. 2020 Feb;32(2):276-284. doi: 10.1097/MEG.0000000000001649.

PMID:
31895887
4.

Multidrug-Resistant Bacteria and Disease Progression in Patients with End-Stage Liver Disease and after Liver Transplantation.

Friedrich K, Krempl J, Schamoni S, Hippchen T, Pfeiffenberger J, Rupp C, Gotthardt DN, Houben P, Von Haken R, Heininger A, Brenner T, Mehrabi A, Weiss KH, Mieth M.

J Gastrointestin Liver Dis. 2019 Sep 1;28(3):303-310. doi: 10.15403/jgld-212.

5.

Association between serum IgG level and clinical course in primary sclerosing cholangitis.

Hippchen T, Sauer P, Göppert B, Schirmacher P, Gotthardt DN, Weiss KH, Stremmel W, Rupp C.

BMC Gastroenterol. 2019 Aug 27;19(1):153. doi: 10.1186/s12876-019-1075-0.

6.

Prevalence of human herpesviruses in biliary fluid and their association with biliary complications after liver transplantation.

Rauber C, Bartelheimer K, Zhou T, Rupp C, Schnitzler P, Schemmer P, Sauer P, Weiss KH, Gotthardt DN.

BMC Gastroenterol. 2019 Jun 27;19(1):110. doi: 10.1186/s12876-019-1033-x.

7.

Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are associated with biliary damage and graft survival in a case-control study.

Rauber C, Awad M, Koschny R, Sauer P, Mehrabi A, Gath P, Weiss KH, Gotthardt DN, Rupp C.

Clin Res Hepatol Gastroenterol. 2020 Feb;44(1):38-48. doi: 10.1016/j.clinre.2019.05.005. Epub 2019 Jun 11.

PMID:
31201006
8.

Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis.

Rupp C, Hippchen T, Bruckner T, Klöters-Plachky P, Schaible A, Koschny R, Stiehl A, Gotthardt DN, Sauer P.

Gut. 2019 Dec;68(12):2170-2178. doi: 10.1136/gutjnl-2018-316801. Epub 2019 Mar 25.

9.

Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis.

Wannhoff A, Brune M, Knierim J, Weiss KH, Rupp C, Gotthardt DN.

Aliment Pharmacol Ther. 2019 Mar;49(6):769-778. doi: 10.1111/apt.15146. Epub 2019 Jan 27.

PMID:
30687954
10.

Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis.

Wannhoff A, Gotthardt DN.

Clin Res Hepatol Gastroenterol. 2019 Jun;43(3):236-243. doi: 10.1016/j.clinre.2018.08.013. Epub 2018 Sep 25. Review.

PMID:
30266579
11.

Epigenetic changes of the thioredoxin system in the tx-j mouse model and in patients with Wilson disease.

Mordaunt CE, Shibata NM, Kieffer DA, Czlonkowska A, Litwin T, Weiss KH, Gotthardt DN, Olson K, Wei D, Cooper S, Wan YY, Ali MR, LaSalle JM, Medici V.

Hum Mol Genet. 2018 Nov 15;27(22):3854-3869. doi: 10.1093/hmg/ddy262.

12.

Serum miRNA-122 is an independent biomarker of survival in patients with primary sclerosing cholangitis.

Friedrich K, Baumann C, Wannhoff A, Rupp C, Mehrabi A, Weiss KH, Gotthardt DN.

J Gastrointestin Liver Dis. 2018 Jun;27(2):145-150. doi: 10.15403/jgld.2014.1121.272.cho.

13.

Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus.

Rupp C, Hippchen T, Neuberger M, Sauer P, Pfeiffenberger J, Stremmel W, Gotthardt DN, Mehrabi A, Weiss KH.

World J Gastroenterol. 2018 Mar 28;24(12):1353-1360. doi: 10.3748/wjg.v24.i12.1353.

14.

Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis.

Rupp C, Rössler A, Zhou T, Rauber C, Friedrich K, Wannhoff A, Weiss KH, Sauer P, Schirmacher P, Süsal C, Stremmel W, Gotthardt DN.

United European Gastroenterol J. 2018 Mar;6(2):255-262. doi: 10.1177/2050640617717156. Epub 2017 Jun 17.

15.

Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.

Rupp C, Bode KA, Leopold Y, Sauer P, Gotthardt DN.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1380-1389. doi: 10.1016/j.bbadis.2017.09.012. Epub 2017 Sep 22.

16.

Pregnancy in Wilson's disease: Management and outcome.

Pfeiffenberger J, Beinhardt S, Gotthardt DN, Haag N, Freissmuth C, Reuner U, Gauss A, Stremmel W, Schilsky ML, Ferenci P, Weiss KH.

Hepatology. 2018 Apr;67(4):1261-1269. doi: 10.1002/hep.29490. Epub 2018 Feb 18.

PMID:
28859232
17.

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.

Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, Böttcher K, Folseraas T, Weismüller TJ, Mason AL, Wang W, Alexander G, Alvaro D, Bergquist A, Björkström NK, Beuers U, Björnsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouillères O, Cheung A, Dalekos G, Eaton J, Eksteen B, Ellinghaus D, Färkkilä M, Festen EAM, Floreani A, Franceschet I, Gotthardt DN, Hirschfield GM, Hoek BV, Holm K, Hohenester S, Hov JR, Imhann F, Invernizzi P, Juran BD, Lenzen H, Lieb W, Liu JZ, Marschall HU, Marzioni M, Melum E, Milkiewicz P, Müller T, Pares A, Rupp C, Rust C, Sandford RN, Schramm C, Schreiber S, Schrumpf E, Silverberg MS, Srivastava B, Sterneck M, Teufel A, Vallier L, Verheij J, Vila AV, Vries B, Zachou K; International PSC Study Group, The UK PSC Consortium, Chapman RW, Manns MP, Pinzani M, Rushbrook SM, Lazaridis KN, Franke A, Anderson CA, Karlsen TH, Ponsioen CY, Weersma RK.

Gut. 2018 Aug;67(8):1517-1524. doi: 10.1136/gutjnl-2016-313598. Epub 2017 Aug 4.

18.

Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.

Dröge C, Bonus M, Baumann U, Klindt C, Lainka E, Kathemann S, Brinkert F, Grabhorn E, Pfister ED, Wenning D, Fichtner A, Gotthardt DN, Weiss KH, McKiernan P, Puri RD, Verma IC, Kluge S, Gohlke H, Schmitt L, Kubitz R, Häussinger D, Keitel V.

J Hepatol. 2017 Dec;67(6):1253-1264. doi: 10.1016/j.jhep.2017.07.004. Epub 2017 Jul 19.

PMID:
28733223
19.

Comparative assessment of clinical rating scales in Wilson's disease.

Volpert HM, Pfeiffenberger J, Gröner JB, Stremmel W, Gotthardt DN, Schäfer M, Weiss KH, Weiler M.

BMC Neurol. 2017 Jul 21;17(1):140. doi: 10.1186/s12883-017-0921-3.

20.

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E; UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D, Yu L, Bowlus CL, Franke A, Lie BA, Karlsen TH.

HLA. 2017 Oct;90(4):228-233. doi: 10.1111/tan.13076. Epub 2017 Jul 11.

PMID:
28695657

Supplemental Content

Loading ...
Support Center